Rifampin is an antibacterial agent active against many gram-positive cocci, Mycobacteria, Clostridium difficle, and select gram-negative organisms, namely Neisseria meningitides, Neisseria gonorrhoeae, and Hemophilus influenzae. Clinically, rifampin is recommended for infections where the disease-causing organisms are identified and their drug susceptibility has been determined. To prevent drug resistance, rifampin is usually combined with other antimicrobial agents.Hemophilus influenzae carriers who can transmit the infection to children less than four years. It is also beneficial as a second-line agent for the treatment of cholestatic pruritis.Mycobacterium tuberculosis. Rifampin is administered alongside isoniazid, ethambutol, and pyrazinamide for the first two months, followed by four months of only rifampin and isoniazid.